This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Szabo, M. Articles by Schwartz, N. B. Search for Related Content PubMed PubMed Citation Articles by Szabo, M. Articles by Schwartz, N. B.

Antiprogestins Suppress Basal and Activin-Stimulated Follicle-Stimulating Hormone Secretion in an Estrogen-Dependent Manner¹

Department of Neurobiology and Physiology, Northwestern University, Evanston, Illinois 60208

Address all correspondence and requests for reprints to: Marta Szabo, Ph.D., Department of Neurobiology and Physiology, Northwestern University, 2153 North Campus Drive, Evanston, Illinois 60208-3520. E-mail: msz729{at}nwu.edu

Previous studies from our laboratory, demonstrating that suppression of serum FSH by RU486 requires a high estrogen (E) background, suggested that E-inducible progesterone receptors play a role in the regulation of FSH secretion. We demonstrated further that the type II antiprogestin RU486 and the type I antiprogestin ZK98299 both suppressed the elevated serum FSH and FSHß messenger RNA levels similarly on the evening of proestrus, but had divergent effects on the morning of estrus, when only RU486, but not ZK98299, lowered the elevated serum FSH level (secondary FSH surge). In the present work we used primary anterior pituitary cell culture to examine whether RU486 caused direct, E-dependent suppression of basal and recombinant human activin A (activin)-induced FSH secretion in the gonadotrope and to compare this direct effect, if any, with that of ZK98299. Primary cell cultures were prepared from anterior pituitaries collected from cycling female rats either on metestrous or proestrous morning and cultured in DMEM, supplemented with charcoal-stripped serum without or with 10 nM estradiol (E₂) for 96 h; exposure to test agents occurred during the last 48 h of culture. FSH released into the medium and intracellular FSH content were determined by RIA. In cells from the anterior pituitary of metestrous rats cultured in E₂-free medium, neither antiprogestin (10 nM) affected FSH release; in contrast, when cells were cultured in medium to which E₂ had been added, both antiprogestins caused profound suppression of both basal and activin (10 ng/ml)-stimulated FSH release. In cell cultures from proestrous rats, both antiprogestins caused a slight, but significant, suppression of basal FSH release even in the absence of added E₂; activin-stimulated FSH release, however, was not affected. Upon exposure of the cells from proestrous rats to E₂, the antiprogestins potently suppressed both basal and activin-stimulated FSH secretion. Because the foregoing incubations were performed in culture medium devoid of progesterone (P₄), the actions of the antiprogestins on FSH secretion were independent of the natural ligand. Addition of P₄ (10 nM) to the cell cultures stimulated basal and activin-induced FSH release more in the presence than in the absence of E₂. The FSH response to P₄ was completely blocked by both antiprogestins in both the absence and presence of E₂. Finally, both RU486 and ZK98299 blocked the stimulatory effect of corticosterone (1 µM) on FSH secretion. The observed effects of P₄ and antiprogestins were specific for FSH secretion; LH secretion was not similarly suppressed by either antiprogestin, but was, in fact, stimulated by ZK98299 in E₂-treated cells. We conclude that 1) E₂-inducible progesterone receptors interact with activin-mediated signal transduction to regulate FSH secretion, and 2) unlike on the morning of estrus in vivo, RU486 and ZK98299 affect FSH secretion similarly in the gonadotrope in vitro.

This article has been cited by other articles:

				R. Sasson, S. H. Luu, V. G. Thackray, and P. L. Mellon Glucocorticoids Induce Human Glycoprotein Hormone {alpha}-Subunit Gene Expression in the Gonadotrope Endocrinology, July 1, 2008; 149(7): 3643 - 3655. [Abstract] [Full Text] [PDF]

				V. G. Thackray, S. M. McGillivray, and P. L. Mellon Androgens, Progestins, and Glucocorticoids Induce Follicle-Stimulating Hormone {beta}-Subunit Gene Expression at the Level of the Gonadotrope Mol. Endocrinol., September 1, 2006; 20(9): 2062 - 2079. [Abstract] [Full Text] [PDF]

				C M Gomes, C Raineki, P R. de Paula, G S Severino, C V V Helena, J A Anselmo-Franci, C R Franci, G L Sanvitto, and A B Lucion Neonatal handling and reproductive function in female rats J. Endocrinol., February 1, 2005; 184(2): 435 - 445. [Abstract] [Full Text] [PDF]

				B. L. Bohnsack, M. Szabo, S. M. Kilen, D. H.Y. Tam, and N. B. Schwartz Follistatin Suppresses Steroid-Enhanced Follicle-Stimulating Hormone Release In Vitro in Rats Biol Reprod, March 1, 2000; 62(3): 636 - 641. [Abstract] [Full Text]

				M. Szabo, S. M. Kilen, S. J. Nho, and N. B. Schwartz Progesterone Receptor A and B Messenger Ribonucleic Acid Levels in the Anterior Pituitary of Rats Are Regulated by Estrogen Biol Reprod, January 1, 2000; 62(1): 95 - 102. [Abstract] [Full Text]